Cargando…

Inactivated SARS-CoV-2 vaccine for people with HIV

Detalles Bibliográficos
Autores principales: Wolday, Dawit, de Wit, Tobias F. Rinke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898081/
https://www.ncbi.nlm.nih.gov/pubmed/35265824
http://dx.doi.org/10.1016/j.eclinm.2022.101327
_version_ 1784663569420255232
author Wolday, Dawit
de Wit, Tobias F. Rinke
author_facet Wolday, Dawit
de Wit, Tobias F. Rinke
author_sort Wolday, Dawit
collection PubMed
description
format Online
Article
Text
id pubmed-8898081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88980812022-03-07 Inactivated SARS-CoV-2 vaccine for people with HIV Wolday, Dawit de Wit, Tobias F. Rinke EClinicalMedicine Commentary Elsevier 2022-03-05 /pmc/articles/PMC8898081/ /pubmed/35265824 http://dx.doi.org/10.1016/j.eclinm.2022.101327 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Wolday, Dawit
de Wit, Tobias F. Rinke
Inactivated SARS-CoV-2 vaccine for people with HIV
title Inactivated SARS-CoV-2 vaccine for people with HIV
title_full Inactivated SARS-CoV-2 vaccine for people with HIV
title_fullStr Inactivated SARS-CoV-2 vaccine for people with HIV
title_full_unstemmed Inactivated SARS-CoV-2 vaccine for people with HIV
title_short Inactivated SARS-CoV-2 vaccine for people with HIV
title_sort inactivated sars-cov-2 vaccine for people with hiv
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898081/
https://www.ncbi.nlm.nih.gov/pubmed/35265824
http://dx.doi.org/10.1016/j.eclinm.2022.101327
work_keys_str_mv AT woldaydawit inactivatedsarscov2vaccineforpeoplewithhiv
AT dewittobiasfrinke inactivatedsarscov2vaccineforpeoplewithhiv